ArticleInternational journal of hematology2021

Humanized anti CD-20 as an alternative in chronic management of relapsing thrombotic thrombocytopenic microangiopathy resistant to rituximab due to anti chimeric antibody.

Pedram Ahmadpoor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.